Portal vein thrombosis natural history, complications and prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farima Kahe M.D. [2]
Overview
Overview
If left untreated, patients with portal vein thrombosis may progress to develop portal cavernoma, gastric or esophageal varices/bleeding, hepatic encephalopathy, splenomegaly, portal biliopathy, and cholangiopathy. Depending on the extent of the model for end-stage liver disease score at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as good.
Natural History, Complications, and Prognosis
Natural History, Complications, and Prognosis
Natural History
- There is usually subclinical prothrombotic state in about in about 72% of idiopathic portal vein thrombosis.
- If left untreated, patients with portal vein thrombosis may progress to develop portal cavernoma, gastric or esophageal varices/bleeding, hepatic encephalopathy, splenomegaly, portal biliopathy, and cholangiopathy.[1]
Complications
- Common complications of portal vein thrombosis include:[2][3][4][5][6]
- Portal cavernoma
- Gastric or esophageal varices/bleeding
- Hepatic encephalopathy
- Portal biliopathy or cholangiopathy
- Thrombocytopenia
- Splenomegaly
- Ascites
- Peritonitis
- Hypoxia
- Pulmonary artery hypertension
- Portal hypertensive gastropathy
Prognosis
- The 1 year mortality rate of patients with chronic portal vein thrombosis is approximately 80%-95% and the 3 year mortality rate of patients with chronic portal vein thrombosis is approximately 75%-90%.[7][8][9]
- Mortality in patients with cancer or cirrhosis in one year is 26% and those without cancer or cirrhosis is 8%.[3]
- Depending on the extent of the model for end-stage liver disease score at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as good.[10]
- Morbidity and mortality is associated with following factors:[7]
- Increasing age
- Recurrent thrombosis
- Portal cholangiopathy
- Progression of the underlying myeloproliferative disease or its transformation into acute leukemia
References
References
- ↑ Chawla YK, Bodh V (2015). “Portal vein thrombosis”. J Clin Exp Hepatol. 5 (1): 22–40. doi:10.1016/j.jceh.2014.12.008. PMC 4415192. PMID 25941431.
- ↑ Trebicka J, Strassburg CP (2014). “Etiology and Complications of Portal Vein Thrombosis”. Viszeralmedizin. 30 (6): 375–80. doi:10.1159/000369987. PMC 4513836. PMID 26288604.
- ↑ 3.0 3.1 Condat B, Pessione F, Hillaire S, Denninger MH, Guillin MC, Poliquin M, Hadengue A, Erlinger S, Valla D (2001). “Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy”. Gastroenterology. 120 (2): 490–7. PMID 11159889.
- ↑ Garcia-Pagán JC, Hernández-Guerra M, Bosch J (2008). “Extrahepatic portal vein thrombosis”. Semin. Liver Dis. 28 (3): 282–92. doi:10.1055/s-0028-1085096. PMID 18814081.
- ↑ Condat B, Vilgrain V, Asselah T, O’Toole D, Rufat P, Zappa M, Moreau R, Valla D (2003). “Portal cavernoma-associated cholangiopathy: a clinical and MR cholangiography coupled with MR portography imaging study”. Hepatology. 37 (6): 1302–8. doi:10.1053/jhep.2003.50232. PMID 12774008.
- ↑ Dhiman RK, Behera A, Chawla YK, Dilawari JB, Suri S (2007). “Portal hypertensive biliopathy”. Gut. 56 (7): 1001–8. doi:10.1136/gut.2006.103606. PMC 1994341. PMID 17170017.
- ↑ 7.0 7.1 Parikh, Sameer; Shah, Riddhi; Kapoor, Prashant (2010). “Portal Vein Thrombosis”. The American Journal of Medicine. 123 (2): 111–119. doi:10.1016/j.amjmed.2009.05.023. ISSN 0002-9343.
- ↑ Sogaard KK, Astrup LB, Vilstrup H, Gronbaek H (2007). “Portal vein thrombosis; risk factors, clinical presentation and treatment”. BMC Gastroenterol. 7: 34. doi:10.1186/1471-230X-7-34. PMC 1976099. PMID 17697371.
- ↑ Amitrano L, Guardascione MA, Scaglione M, Pezzullo L, Sangiuliano N, Armellino MF, Manguso F, Margaglione M, Ames PR, Iannaccone L, Grandone E, Romano L, Balzano A (2007). “Prognostic factors in noncirrhotic patients with splanchnic vein thromboses”. Am. J. Gastroenterol. 102 (11): 2464–70. doi:10.1111/j.1572-0241.2007.01477.x. PMID 17958760.
- ↑ Janssen HL, Wijnhoud A, Haagsma EB, van Uum SH, van Nieuwkerk CM, Adang RP, Chamuleau RA, van Hattum J, Vleggaar FP, Hansen BE, Rosendaal FR, van Hoek B (2001). “Extrahepatic portal vein thrombosis: aetiology and determinants of survival”. Gut. 49 (5): 720–4. PMC 1728504. PMID 11600478.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
